Revolution Medicines: Pay

Revolution Medicines paid its 5 named executives $32.8M in total in FY2025 (Dec). CEO Mark A. Goldsmith, M.D., Ph.D. was paid $14.7M of that.

Pay$100 in the stock at the end of FY20 → $201
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Mark A. Goldsmith, M.D., Ph.D.President and Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Steve Kelsey, M.D., FRCP, FRCPathPresident, Research and Development
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Margaret Horn, J.D.Chief Operating Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Jeffrey CisliniGeneral Counsel and Secretary
FY2025 (Dec)
FY2024 (Dec)Not disclosed
FY2023 (Dec)Not disclosed
3 years
Jack AndersChief Financial Officer
FY2025 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
4 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 4 peers with pay on file was $11.9M. The CEO of Revolution Medicines was paid $14.7M, 23% above the median.

  1. 1Madrigal Pharmaceuticals
  2. 2Revolution Medicines
  3. 3Ionis Pharmaceuticals
  4. 4Krystal Biotech
  5. 5CRISPR Therapeutics AG
  6. 6Apellis PharmaceuticalsNot disclosed
  7. 7Arrowhead PharmaceuticalsNot disclosed
  8. 8ArvinasNot disclosed
  9. 9Blueprint MedicinesNot disclosed
  10. 10Cerevel TherapeuticsNot disclosed
  11. 11CytokineticsNot disclosed
  12. 12Denali TherapeuticsNot disclosed
  13. 13Intellia TherapeuticsNot disclosed
  14. 14Intra-Cellular TherapeuticsNot disclosed
  15. 15NuvalentNot disclosed
  16. 16Roivant SciencesNot disclosed
  17. 17SpringWorks TherapeuticsNot disclosed
  18. 18VaxcyteNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.